anova with tukey’s multiple comparisons test graphpad prism version 10.2.0 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
anova with tukey’s multiple comparisons test graphpad prism version 10.2.0
Anova With Tukey’s Multiple Comparisons Test Graphpad Prism Version 10.2.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anova+with+tukey%E2%80%99s+multiple+comparisons+test+graphpad+prism+version+10%2E2%2E0/anova+followed+by+tukey%E2%80%99s+post+hoc+test/pm40249815-378-10-17
Average 90 stars, based on 1 article reviews
Anova With Tukey’s Multiple Comparisons Test Graphpad Prism Version 10.2.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anova+with+tukey%E2%80%99s+multiple+comparisons+test+graphpad+prism+version+10%2E2%2E0/anova+followed+by+tukey%E2%80%99s+post+hoc+test/pm40249815-378-10-17
Average 90 stars, based on 1 article reviews
anova with tukey’s multiple comparisons test graphpad prism version 10.2.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: A genetic variant in SMAD7 acts as a modifier of LMNA -associated muscular dystrophy, implicating SMAD signaling as a therapeutic target. Article Snippet: Statistical significance was determined using a one- way analysis of variance (ANOVA) with Tukey’s Article Title: A genetic variant in SMAD7 acts as a modifier of LMNA -associated muscular dystrophy, implicating SMAD signaling as a therapeutic target Article Snippet: Statistical significance was determined using a one-way analysis of variance (ANOVA) with Tukey’s |